X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (21) 21
male (21) 21
pulmonary/respiratory (20) 20
index medicus (18) 18
middle aged (18) 18
female (17) 17
respiratory system (16) 16
aged (15) 15
pulmonary disease, chronic obstructive - drug therapy (14) 14
double-blind method (11) 11
treatment outcome (11) 11
tropanes - administration & dosage (11) 11
tropanes - adverse effects (11) 11
pulmonary disease, chronic obstructive - physiopathology (10) 10
administration, inhalation (9) 9
muscarinic antagonists - adverse effects (9) 9
obstructive pulmonary-disease (9) 9
pharmacokinetics (9) 9
quality of life (9) 9
safety (9) 9
copd (8) 8
drug administration schedule (8) 8
forced expiratory volume (8) 8
muscarinic antagonists - administration & dosage (8) 8
tiotropium (8) 8
tropanes - therapeutic use (8) 8
adult (7) 7
allergic rhinitis (7) 7
care and treatment (7) 7
drug therapy (7) 7
nose (7) 7
olopatadine (7) 7
rhinitis (7) 7
aclidinium (6) 6
allergy (6) 6
asthma (6) 6
bronchodilation (6) 6
chronic obstructive pulmonary disease (6) 6
histamine (6) 6
lung diseases, obstructive (6) 6
muscarinic antagonists - therapeutic use (6) 6
patients (6) 6
pulmonary and respiratory medicine (6) 6
aclidinium bromide (5) 5
bromide (5) 5
bronchodilator agents - administration & dosage (5) 5
bronchodilator agents - adverse effects (5) 5
bronchodilator agents - therapeutic use (5) 5
dose-response relationship, drug (5) 5
dry powder inhalers (5) 5
dyspnea - drug therapy (5) 5
fluticasone (5) 5
health status (5) 5
lung-function (5) 5
quality-of-life (5) 5
respiratory tract diseases (5) 5
salmeterol (5) 5
severity of illness index (5) 5
clinical trials (4) 4
corticosteroids (4) 4
cross-over studies (4) 4
dyspnea (4) 4
effectiveness (4) 4
outcomes (4) 4
pharmaceutical industry (4) 4
pharmacology & pharmacy (4) 4
research (4) 4
studies (4) 4
surveys and questionnaires (4) 4
tolerability (4) 4
adults (3) 3
cardiac & cardiovascular systems (3) 3
comparative analysis (3) 3
confidence intervals (3) 3
device (3) 3
dyspnea - etiology (3) 3
exacerbations (3) 3
exercise (3) 3
fluticasone propionate (3) 3
hyperinflation (3) 3
impact (3) 3
inhalers (3) 3
laboratories (3) 3
long-acting muscarinic antagonist (3) 3
medical research (3) 3
medicine, experimental (3) 3
metered-dose inhaler (3) 3
mortality (3) 3
muscarinic antagonist (3) 3
patient outcomes (3) 3
placebo (3) 3
pulmonary disease, chronic obstructive - complications (3) 3
randomization (3) 3
respiratory function tests (3) 3
respiratory therapy (3) 3
time factors (3) 3
young adult (3) 3
administered twice (2) 2
adverse events (2) 2
allergy and immunology (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Respiratory research, ISSN 1465-9921, 2014, Volume 15, Issue 1, pp. 123 - 123
Background: Combining two long-acting bronchodilators with complementary mechanisms of action may provide treatment benefits to patients with chronic... 
Formoterol | Dyspnea | Health status | Lung function | Aclidinium | COPD | MODERATE | HYPERINFLATION | BRONCHODILATION | MAINTENANCE | OBSTRUCTIVE PULMONARY-DISEASE | RESPIRATORY SYSTEM | TIOTROPIUM | BROMIDE | ACCORD COPD | FLUTICASONE | Bronchodilator Agents - administration & dosage | Humans | Middle Aged | Muscarinic Antagonists - adverse effects | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | North America | Recovery of Function | Forced Expiratory Volume | Time Factors | Adrenergic beta-2 Receptor Agonists - adverse effects | Female | Bronchodilator Agents - adverse effects | Tropanes - administration & dosage | Pulmonary Disease, Chronic Obstructive - diagnosis | Tropanes - adverse effects | Dry Powder Inhalers | Double-Blind Method | Drug Administration Schedule | Formoterol Fumarate - adverse effects | Administration, Inhalation | Treatment Outcome | Dyspnea - physiopathology | Lung - physiopathology | New Zealand | Muscarinic Antagonists - administration & dosage | Lung - drug effects | Adrenergic beta-2 Receptor Agonists - administration & dosage | Dyspnea - drug therapy | Aged | Australia | Health Status | Drug Combinations | Formoterol Fumarate - administration & dosage | Pulmonary Disease, Chronic Obstructive - drug therapy | Medicine, Experimental | Pharmaceutical industry | Medical research | Studies | Heart attacks | Laboratories | Smooth muscle | Chronic obstructive pulmonary disease | Drug therapy | Research
Journal Article
The Journal of Allergy and Clinical Immunology, ISSN 0091-6749, 02/2019, Volume 143, Issue 2, pp. AB63 - AB63
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2016, Volume 139, Issue 2, pp. AB97 - AB97
  Methods This phase 3, double-blind, parallel-group study (FSS-AS-30017; NCT02141854) evaluated asthmatic patients (ages >=12 years) previously taking inhaled... 
Allergy and Immunology | Care and treatment | Powders | Patient outcomes | Fluticasone | Comparative analysis | Asthma | Steroids | Respiratory therapy | Patients | Quality of life
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2016, Volume 139, Issue 2, pp. AB10 - AB10
  Methods This phase 3, double-blind, parallel-group study (FSS-AS-301; NCT02139644) evaluated asthmatic patients (ages >=12 years) using inhaled... 
Allergy and Immunology | Care and treatment | Powders | Fluticasone | Patient outcomes | Asthma | Steroids | Prescription drugs | Patients | Quality of life
Journal Article
Journal Article
Journal Article
The Journal of Allergy and Clinical Immunology, ISSN 0091-6749, 02/2018, Volume 141, Issue 2, pp. AB170 - AB170
Rationale In two randomized double-blind studies, twice-daily GSP301 nasal spray-a fixed-dose combination of olopatadine hydrochloride and mometasone... 
Studies | Histamine | Rhinitis | Allergic rhinitis | Nose | Olopatadine
Journal Article
The Journal of Allergy and Clinical Immunology, ISSN 0091-6749, 02/2018, Volume 141, Issue 2, pp. AB173 - AB173
Rationale Combining an intranasal antihistamine with an intranasal corticosteroid for the treatment of allergic rhinitis (AR) may provide improved symptom... 
Histamine | Rhinitis | Allergic rhinitis | Nose | Olopatadine
Journal Article
Respiratory Medicine, ISSN 0954-6111, 2013, Volume 107, Issue 12, pp. 1957 - 1965
Journal Article
Annals of Allergy, Asthma & Immunology, ISSN 1081-1206, 06/2019, Volume 122, Issue 6, pp. 630 - 638.e3
GSP301 nasal spray is a fixed-dose combination of olopatadine hydrochloride (antihistamine) and mometasone furoate (corticosteroid). To evaluate the efficacy... 
Journal Article
Respiratory Research, ISSN 1465-9921, 12/2011, Volume 12, Issue 1, pp. 1 - 10
The long-term efficacy and safety of aclidinium bromide, a novel, long-acting muscarinic antagonist, were investigated in patients with moderate to severe... 
Aclidinium bromide | Pneumology/Respiratory System | Medicine & Public Health | long-acting muscarinic antagonist | anticholinergic | chronic obstructive pulmonary disease | Chronic obstructive pulmonary disease | Anticholinergic | Long-acting muscarinic antagonist | TRIAL | BRONCHODILATOR | Aclidinium bromide anticholinergic | RESPIRATORY SYSTEM | LUNG-FUNCTION | EXACERBATIONS | PREVENTION | TIOTROPIUM | BROMIDE | OUTCOMES | Bronchodilator Agents - administration & dosage | Humans | Middle Aged | Muscarinic Antagonists - adverse effects | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | North America | Forced Expiratory Volume | Time Factors | Female | Surveys and Questionnaires | Bronchodilator Agents - adverse effects | Tropanes - administration & dosage | Severity of Illness Index | Pulmonary Disease, Chronic Obstructive - diagnosis | Tropanes - adverse effects | Dry Powder Inhalers | Double-Blind Method | Drug Administration Schedule | Europe | Administration, Inhalation | Logistic Models | Treatment Outcome | Dyspnea - physiopathology | Lung - physiopathology | Muscarinic Antagonists - administration & dosage | Lung - drug effects | Quality of Life | Dyspnea - drug therapy | Aged | Health Status | Pulmonary Disease, Chronic Obstructive - drug therapy | Lung diseases, Obstructive | Care and treatment | Diagnosis | Research | Medicine, Experimental | Medical research | Health surveys | Malalties pulmonars obstructives cròniques | Chronic obstructive pulmonary diseases
Journal Article
Journal of Asthma, ISSN 0277-0903, 08/2018, Volume 55, Issue 8, pp. 898 - 906
Objective: Characterize fluticasone propionate (Fp) and combination fluticasone propionate and salmeterol (FS) pharmacokinetic and safety profiles, delivered... 
long-acting beta-2 agonists | Adverse events | delivery device | inhaled corticosteroid | tolerability | ALLERGY | RESPIRATORY SYSTEM | CORTICOSTEROIDS | SALMETEROL
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.